tiprankstipranks
Trending News
More News >
Kissei Pharmaceutical Co Ltd (JP:4547)
:4547
Japanese Market

Kissei Pharmaceutical Co (4547) Income Statement

Compare
0 Followers

Kissei Pharmaceutical Co Income Statement

Last quarter (Q1 2026), Kissei Pharmaceutical Co's total revenue was ¥22.19B, an increase of 4.85% from the same quarter last year. In Q1, Kissei Pharmaceutical Co's net income was ¥4.52B. See Kissei Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 88.33B¥ 75.58B¥ 67.49B¥ 65.38B¥ 69.04B
Gross Profit
¥ 44.06B¥ 37.34B¥ 32.38B¥ 31.24B¥ 32.72B
Operating Expenses
¥ 38.29B¥ 33.32B¥ 33.50B¥ 32.64B¥ 31.22B
Depreciation and Amortization
¥ 4.62B¥ 4.25B¥ 4.11B¥ 3.73B¥ 3.15B
EBITDA
¥ 20.25B¥ 18.72B¥ 17.81B¥ 20.26B¥ 10.65B
Operating Income
¥ 5.77B¥ 4.02B¥ -1.13B¥ -1.40B¥ 1.50B
Other Income/Expenses
¥ 9.84B¥ 10.43B¥ 14.81B¥ 17.91B¥ 5.97B
Pretax Income
¥ 15.61B¥ 14.45B¥ 13.68B¥ 16.51B¥ 7.48B
Net Income
¥ 11.96B¥ 11.16B¥ 10.53B¥ 12.92B¥ 5.29B
Per Share Metrics
Basic EPS
¥ 274.20¥ 246.58¥ 228.30¥ 280.19¥ 113.25
Diluted EPS
¥ 274.20¥ 246.58¥ 228.30¥ 280.19¥ 113.25
Weighted Average Shares Outstanding
43.62M 45.26M 46.12M 46.12M 46.67M
Weighted Average Shares Outstanding (Diluted)
43.62M 45.26M 46.12M 46.12M 46.67M
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History